The Panorama Institute of Molecular Medicine (EIN 770305799) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1991

Legal Domicile

Principal Officer

JAMES W LARRICK

Phone

4087475201

Tax Period

2024-07-01 to 2025-06-30

The Panorama Institute of Molecular Medicine, founded in 1991, is a micro nonprofit in the Medical Research sector that reported $65K in total revenue in fiscal year 2024. Revenue fell 71% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $23K, a strong 36% operating margin.

Mission

THE ORGANIZATION PERFORMS RESEARCH, DEVELOPS AND ADVANCES INNOVATIVE MEDICINES FOR IMPROVING HUMAN HEALTH AND SAVING LIVES WHICH WILL ULTIMATELY SERVE THE ENTIRE POPULATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,000

Program Service Revenue $19,091

Investment Income $44,222

Other Revenue $0

TOTAL REVENUE $65,313

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $34,037

Other Expenses $42,054

TOTAL EXPENSES $42,054

Year-over-Year Comparison

	2024	2023	Change
Revenue	$65,313	$222,084	-0.7%
Expenses	$42,054	$247,516	-0.8%
Net Income	$23,259	$-25,432	-1.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JAMES W LARRICK	CHIEF EXECUTIVE OFFICER	10.00	Officer	$0	$0	$0
DONALD LARRICK	SECRETARY	10.00	Officer	$0	$0	$0
JAMES W LARRICK	CHIEF FINANCIAL OFFICER	0.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$65,313	$42,054	$818,436	$23,259
2024	No data	No data	No data	No data
2023	$245,797	$70,316	$843,701	$175,481
2021	$187,987	$32,198	$742,286	$155,789
2020	$176,100	$134,044	$582,417	$42,056
2019	$214,431	$114,044	$606,511	$100,387

The Panorama Institute of Molecular Medicine